Both CB1 and CB2 seem to be expressed in many types of cancer, including lung cancer [11,14,15,16,17], supporting the hypothesis that cannabinoids might interfere with tumors by acting on CB1 and CB2 receptors. This evidence concerns the gene CNR1 and lung carcinoma.